Boehringer and Lilly gain FDA approval for kidney disease therapy
Boehringer and Eli Lilly have received approval from the US FDA for Jardiance to treat adults with chronic kidney disease (CKD).
Boehringer and Eli Lilly have received approval from the US FDA for Jardiance to treat adults with chronic kidney disease (CKD).
What's Your Reaction?
